SCGB3A1 and Familial prostate cancer: We observed several EV proteins, particularly SERPINA3, LRG1, and SCGB3A1, which showed a consistent difference between prostate cancer cases and non-prostate cancer controls across three DIA methods, which could be suggested as potential biomarkers and deserve further verification.